Intestinal epithelial tight junction protein (No universal abbreviation; individual components have their own abbreviations: Occludin (OCLN), Claudin(s) (CLDN), Junctional adhesion molecule(s) (JAM), Zonula occludens 1/2/3 (ZO-1/ZO-2/ZO-3).)

The term “intestinal epithelial tight junction protein” does not refer to one unique molecule but rather describes several structurally distinct transmembrane and scaffolding/adaptor proteins—including Occludin, Claudins, Junctional adhesion molecules (JAMs), and Zonula occludens family members—that together form multiprotein complexes at the apical region between adjacent intestinal epithelial cells. These complexes regulate paracellular permeability (“gate” function), maintain cell polarity (“fence” function), prevent pathogen invasion/toxin diffusion from the gut lumen into tissue compartments, and link directly with intracellular cytoskeleton elements through adaptor/scaffold interactions. Disruption or dysregulation contributes significantly to various gastrointestinal diseases including inflammation/infection/cancer progression. However, because this designation encompasses multiple distinct gene products/proteins rather than one canonical entity—and because each component has unique structure/function relationships—it should always be specified which particular member is being referenced when considering therapeutic targeting strategies.

Other names

Tight junction proteinsTJ proteins

Drugs that affect these targets generally act by modulating transcription/expression levels via cytokine signaling pathways (e.g., IL-1β/NF-κB pathway) leading to increased permeability by downregulating TJ components like Occludin or ZO-proteins, or by stabilizing/disrupting cytoskeletal interactions. These mechanisms are indirect unless targeting an individual member specifically.